Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Cost

GBI Research's new report "Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Cost" provides an in-depth analysis on the potential applications of biomarkers in pharmaceutical drug discovery and clinical services. The report suggests investment decisions in biomarker based drug research by providing information on valid biomarkers, pipelines, case studies, competitive landscape, geographical dominance, mergers and acquisitions and market potential. It also provides an analysis on the trends prevailing in the global biomarkers market. In addition to this, the report also covers market drivers and Restrains for the global biomarkers market.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline

GBI Research's new report "Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline" provides an insight into the global biotechnology industry and analyses the competitive positioning of the top 10 companies in the industry. The report estimates the market size of the global biotechnology industry and its future prospects. It benchmarks the leading companies in the biotechnology industry on selected parameters to analyze their competitive positioning in the market. The future landscape of the biotechnology industry is also analysed by forecasting the revenues of leading companies till 2012. For each company this report analyses the financial strength, product portfolio, pipeline strength and therapeutic focus of its R&D activities. It critically examines the strengths and weaknesses of individual companies and the opportunities and threats facing them.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

The Japanese Pharmaceutical Market Outlook to 2014: Policy environment, market structure, competitive landscape, growth opportunities

Japan, the second single largest drug market in the world (historically known to be a land of innovation) is a leading nation in terms of scientific research, technology, machinery and medical research. Japan has been an industrially active nation ever since it adopted Western technology and gained industrial supremacy in the early years of the 20th century.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

Daiichi Sankyo Co., Ltd: PharmaVitae Profile

This analysis examines the historical and forecast performance for Daiichi Sankyo in the Rx pharmaceutical sector.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

Daiichi Sankyo: new influenza drug may boost flagging Japanese market

Tokyo-based Daiichi Sankyo has filed a New Drug Application in Japan for its inhaled influenza antiviral, laninamivir. This neuraminidase inhibitor, administered in just a single inhaled dose, retains activity to strains resistant to the market leader, Roche's Tamiflu. As such, its approval may provide a much-needed boost to the declining Japanese antiviral market.

Using knowledge brokering to improve business processes

Over the past decade, open innovation has begun transforming the way global companies develop new products, as executives increasingly recognize the benefits of exposing internal R&D to outside ideas. Now, some organizations are going even further by applying open-source thinking to improve a range of core business processes. Aided by rapidly changing technology, these leaders are looking outside the gates to develop faster and better solutions to a variety of strategic, operational, and organizational problems.

Download free 9 pages report at our Download Section.

F. Hoffmann-La Roche Ltd.: PharmaVitae Profile

This analysis examines the historical and forecast performance for Roche in the prescription pharmaceutical sector.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

Roche: novel Herceptin formulation promises greater convenience

Having stepped up lifecycle management for its leading breast cancer monoclonal antibody, Herceptin, Roche hopes to encourage uptake of a more convenient formulation of the drug. This strategy could help to conserve its share of an increasingly competitive market, but may be challenging to implement due to concerns over compliance and financial incentives to prescribe intravenous cancer drugs.

The CMO Market Outlook: Emerging markets, key players and future trends

Falling productivity and patent expiries are placing increasing pressure on pharmaceutical companies to reduce fixed costs, including large manufacturing facilities. Sponsors are turning to contract manufacturing organizations (CMOs) in search of time and cost savings, and as a way to flexibly manage outsourced manufacturing.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

The US Pharmaceutical Market Outlook To 2014: Market trends, leading players and forecasts

This report provides comprehensive coverage of the US pharma market, incorporating the market structure, pricing and regulation, in addition to detailed analysis of leading companies and potential healthcare reforms. This report highlights the key market and R&D trends that may influence treatment sales with a thorough analysis of the competitive dynamics of leading brands within each indication.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

The CRO Market Outlook: Emerging markets, leading players and future trends

This report analyzes the overarching clinical research organization (CRO) trends in the pharma industry, examines which regions are set to see growth in CRO activity, evaluates the leading CROs, and outlines the future of the industry. It also highlights the evolving business and relationship models between CROs and sponsor companies.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

The Ophthalmic Pharmaceutical Market Outlook To 2014: Competitive landscape, pipeline analysis, growth opportunities and market forecasts

This report gives a strategic insight into the global ophthalmic pharmaceutical market in 2008 and discusses its prospects out to 2014.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

US Hip and Knee Implants: Strategic Market Analysis and Insight to 2015

GlobalData's "US Hip and Knee Implants: Strategic Market Analysis and Insight to 2015" report is an essential source of data and analysis on the US hip and knee implants market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on six market categories - primary hip replacement, partial hip replacement, revision hip replacement, primary knee replacement, partial knee replacement and revision knee replacement. The report identifies the key trends shaping and driving the dynamism in the US hip and knee implants market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also provides valuable insight on the pipeline products within the US hip and knee implants market.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

US Computed Tomography (CT) Systems Market: Strategic Analysis and Opportunity Assessment to 2015

GlobalData's "US Computed Tomography (CT) Systems Market: Strategic Analysis and Opportunity Assessment to 2015" report is an essential source of data and analysis on the US CT market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on two market categories - single slice CT and multi slice CT. The report identifies the key trends shaping and driving the dynamism in the US CT market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also provides valuable insight on the pipeline products within the US CT market.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

Europe Nuclear Imaging Equipment: Market Analysis and Opportunity Assessment

GlobalData's "Europe Nuclear Imaging Equipment: Market Analysis and Opportunity Assessment" report is an essential source of data and analysis on the Europe nuclear imaging equipment market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on two market categories - gamma camera, single photon emission computed tomography, and positron emission tomography. The report identifies the key trends shaping and driving the dynamism in the Europe nuclear imaging equipment market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also provides valuable insight on the pipeline products within the Europe nuclear imaging equipment market.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

US Spinal Surgery Devices Market: Increasing Procedures to Drive Growth

A new report by GlobalData, the industry analysis specialist, finds that the increasing incidence of degenerative disc disease and increasing aging population in the US will provide huge growth and investment opportunities for the Spinal surgery market in the US. GlobalData's report, "US Spinal Surgery Devices Market: Increasing Procedures to Drive Growth", highlights this growing aging population as one of the key market drivers for the spinal surgery market in the US.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

US Small Joint Implants Market: The Underlying Demand Drivers Remain in Place

GlobalData's "US Small Joint Implants Market: The Underlying Demand Drivers Remain in Place" report is an essential source of data and analysis on the US small joint implants market with complete coverage by categories. The report provides market landscape, competitive landscape and market trends information on two market categories - ankle replacement, digits replacement, elbow replacement and wrist replacement. The report identifies the key trends shaping and driving the dynamism in the US small joint implants market. The report also provides insight on the prevalent competitive landscape and on the emerging players which are expected to bring significant shift in the market standing of the existing leaders. The report also provides valuable insight on the pipeline products within the US small joint implants market.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!

Increased Investments Boosts The Medical Equipment Market In Q3 2009

GlobalData's "Medical Equipment Quarterly Deals Analysis Q3 2009" report is an essential source of data and trend analysis on the Mergers and Acquisitions (M&A) and financings in the medical equipment market. The report provides detailed information on M&A, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions registered in the medical equipment industry in Q3 2009. The report portrays detailed comparative data on the number of deals and their value in the last five quarters subdivided by deal types, segments, and geographies. Additionally, the report provides information on the top private equity, venture capital, and advisory firms in the medical equipment industry.
Data presented in this report is derived from GlobalData's proprietary in-house Medical eTrack deals database and primary and secondary research.

Claim "10% Discount for Farmavita.Net Members" when purchasing this report!